Susan G. Komen Commends Bill Introductions; Urges Quick Passage ANNAPOLIS, MD – FEBRUARY 3, 2023 – Susan G. Komen®, the world’s leading breast cancer organization, applauds Senator Pamela Beidle (D-Anne Arundel) and Delegate Sheree Sample-Hughes (D-Dorchester) for working with Komen to introduce legislation that would remove financial barriers to imaging that can rule out breast […]

Susan G. Komen® Commends Bill Introduction; Urges Quick Passage OKLAHOMA CITY –Susan G. Komen®, the world’s leading breast cancer organization, applauds Representative Nicole Miller (R-Edmond) for working with Komen to introduce legislation that would prohibit step therapy requirements for metastatic cancer patients. Komen believes patients and their physicians should be able to make treatment decisions […]

Susan G. Komen applauds House lawmakers for their leadership on the bipartisan Metastatic Breast Cancer Access to Care Act, which would make financial benefits and health insurance immediately available to people living with metastatic breast cancer.

Legislation introduced in Minnesota would remove financial barriers to imaging that can rule out breast cancer or confirm the need for a biopsy.

Legislation introduced in Mississippi would remove financial barriers to imaging that can rule out breast cancer or confirm the need for a biopsy.

Legislation introduced in Virginia would remove financial barriers to imaging that can rule out breast cancer or confirm the need for a biopsy

Legislation introduced in Washington would remove financial barriers to imaging that can rule out breast cancer or confirm the need for a biopsy.

Introduction of legislation to eliminate out-of-pocket costs for medically necessary diagnostic and supplemental imaging could make care more affordable and accessible to women in New Mexico.

Susan G. Komen® Commends Bill Introduction; Urges Quick Passage ST. LOUIS, MISSOURI – JANUARY 10, 2023 – Susan G. Komen®, the world’s leading breast cancer organization, applauds Representative Brenda Shields (R-St. Joseph) for working with Komen to introduce legislation that would remove financial barriers to imaging that can rule out breast cancer or confirm the […]

Dr. Ann H. Partridge has been named Chief Scientific Advisor to Susan G. Komen where she’ll help lead Komen’s research investment and strategy.

Susan G. Komen raised $14 million from the 2022 3-Day event series and announced a new location for 2023.

Susan G. Komen advocates called on Congress to immediately pass the pending Metastatic Breast Cancer Access to Care Act to waive unnecessary and burdensome waiting periods for people with the disease to receive federal financial help.